T Wandert

1.0k total citations
9 papers, 744 citations indexed

About

T Wandert is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, T Wandert has authored 9 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in T Wandert's work include Renal cell carcinoma treatment (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Bladder and Urothelial Cancer Treatments (6 papers). T Wandert is often cited by papers focused on Renal cell carcinoma treatment (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Bladder and Urothelial Cancer Treatments (6 papers). T Wandert collaborates with scholars based in Germany, Kazakhstan and United Kingdom. T Wandert's co-authors include Jens Atzpodien, Martina Reitz, Patrick Royston, Paolo Fornara, H. Heynemann, Hartmut Kirchner, Reinhard Hoffmann, Bernd Metzner, Harold C. Schott and Arnold Ganser and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

T Wandert

9 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T Wandert Germany 9 510 383 272 212 190 9 744
Ben Andrews United States 6 331 0.6× 270 0.7× 213 0.8× 231 1.1× 145 0.8× 7 685
Virginia Seery United States 9 286 0.6× 313 0.8× 223 0.8× 122 0.6× 94 0.5× 23 593
S.-Y. Lin China 5 279 0.5× 506 1.3× 172 0.6× 218 1.0× 81 0.4× 5 746
Valentina Guadalupi Italy 14 385 0.8× 225 0.6× 297 1.1× 180 0.8× 194 1.0× 45 637
Farhood Alamdari Sweden 13 431 0.8× 174 0.5× 355 1.3× 162 0.8× 232 1.2× 29 669
Joshua Zhang United States 15 668 1.3× 488 1.3× 375 1.4× 279 1.3× 179 0.9× 56 894
Marta Martín-Richard Spain 17 238 0.5× 483 1.3× 150 0.6× 148 0.7× 190 1.0× 42 708
S D'Emidio Italy 8 267 0.5× 452 1.2× 162 0.6× 117 0.6× 265 1.4× 14 781
A Yagoda United States 11 336 0.7× 259 0.7× 216 0.8× 155 0.7× 197 1.0× 24 604
C. Blajman Argentina 9 425 0.8× 446 1.2× 186 0.7× 94 0.4× 180 0.9× 15 759

Countries citing papers authored by T Wandert

Since Specialization
Citations

This map shows the geographic impact of T Wandert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Wandert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Wandert more than expected).

Fields of papers citing papers by T Wandert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Wandert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Wandert. The network helps show where T Wandert may publish in the future.

Co-authorship network of co-authors of T Wandert

This figure shows the co-authorship network connecting the top 25 collaborators of T Wandert. A scholar is included among the top collaborators of T Wandert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Wandert. T Wandert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Atzpodien, Jens, T Wandert, & Martina Reitz. (2005). Age does not impair the efficacy of immunochemotherapy in patients with metastatic renal carcinoma. Critical Reviews in Oncology/Hematology. 55(3). 193–199. 13 indexed citations
2.
3.
Atzpodien, Jens, Hartmut Kirchner, Udo Jonas, et al.. (2004). Interleukin-2- and Interferon Alfa-2a-Based Immunochemotherapy in Advanced Renal Cell Carcinoma: A Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). Journal of Clinical Oncology. 22(7). 1188–1194. 154 indexed citations
4.
5.
Atzpodien, Jens, et al.. (2003). Metastatic renal carcinoma comprehensive prognostic system. British Journal of Cancer. 88(3). 348–353. 204 indexed citations
6.
7.
Atzpodien, Jens, Hartmut Kirchner, Bernd Metzner, et al.. (2001). IL-2 in combination with IFN-αand 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial. British Journal of Cancer. 85(8). 1130–1136. 95 indexed citations
8.
Wittke, Frederick, Reinhard Hoffmann, Jan Buer, et al.. (1999). Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma. British Journal of Cancer. 79(7-8). 1182–1184. 68 indexed citations
9.
Atzpodien, Jens, Hartmut Kirchner, Anke Franzke, et al.. (1997). A randomized clinical trial comparing SC interleukin-2, SC Alpha-2A-interferon, and IV bolus 5-fluorouracil against oral tamoxifen in progressive metastatic renal cell carcinoma patients. European Journal of Cancer. 33. S36–S37. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ben Andrews Breakdown of academic impact, for papers by Virginia Seery Breakdown of academic impact, for papers by S.-Y. Lin Breakdown of academic impact, for papers by Valentina Guadalupi Breakdown of academic impact, for papers by Farhood Alamdari Breakdown of academic impact, for papers by Joshua Zhang Breakdown of academic impact, for papers by Marta Martín-Richard Breakdown of academic impact, for papers by S D'Emidio Breakdown of academic impact, for papers by A Yagoda Breakdown of academic impact, for papers by C. Blajman
Rankless by CCL
2026